HCA Healthcare Navigates Flat 2027 Outlook Amid Payer Mix Headwinds and Insider Sales

HCA Healthcare, Inc. is preparing for steady service demand alongside restrained earnings momentum heading into 2027. Management projects service volume to expand by 2% to 3% next year. However, company leadership indicated during an October earnings call that 2027 earnings are expected to remain generally consistent with 2026 performance, with comprehensive guidance scheduled for release in January.

The muted earnings projection stems largely from reimbursement headwinds and an unfavorable shift in patient coverage. HCA calculated that an influx of patients moving into uninsured status reduced third-quarter pretax income by 400 million US dollars. Uninsured individuals accounted for 10.5% of equivalent admissions in the quarter, up from 8.5% a year prior. At the same time, exchange-equivalent admissions dropped 19% year over year, with individuals losing exchange coverage shifting to uninsured care at nearly a one-to-one pace.

A drop in state Medicaid support presents an additional challenge. The hospital operator projects a reduction of 550 million to 650 million US dollars in Medicaid supplemental payment net benefits in 2027, as several non-recurring grandfathered state approvals boosted comparisons in 2026. Management is targeting cost performance improvements through an enterprise-wide resiliency program, digital transformation, and shared service expansions to counterbalance these financial pressures.

These headwinds follow strong third-quarter figures, where HCA reported earnings per share of $7.22 on revenue of $19.85 billion, beating consensus expectations of $6.65 per share and $19.33 billion. Revenue rose 3.6% year over year, although operating margin narrowed to 11.9% from 12.6% in the prior-year period. A quarterly dividend of $0.78 per share was declared, payable on Tuesday, December 29th, to stockholders of record as of Tuesday, December 15th.

Recent regulatory disclosures also reveal notable insider activity. COO Jon Foster sold 21,713 shares on Friday, November 6th, at an average price of $494.95, while SVP Erica Rossitto sold 3,500 shares on Tuesday, November 10th, at an average price of $505.81. Additionally, EVP Michael Schlosser sold 1,200 shares on Wednesday, November 4th, bringing total insider sales to 36,413 shares valued at $18,251,464 over the past quarter.